Cyclophosphamide in dogs - Canine Cyclophosphamide
Cyclophosphamide in dogs
Cyclophosphamide (Cytoxan, Mead Johnson, Evansville, Ind) is a very effective immunosuppressive agent for inducing remission in dogs and possibly cats with IMDs. This drug is an alkylator anticancer agent, which appears to suppress cell-mediated and humoral immunity, as well as mononuclear-phagocytic function. It is activated and metabolized by the microsomal fraction of the liver and is available as 25 and 50 mg tablets and injectable vials of 100, 200, 500, and 1000 mg.
Cyclophosphamide has been effective in inducing or consolidating remission in dogs with immune-mediated hemolytic anemia (IHA) or immune-mediated thrombocytopenia (IMT). It is also effective in dogs with immune-mediated polyarthritis, dermatitis, or systemic lupus erythematosus (SLE). It is commonly administered in one dose of 200 to 300 mg/m2 intravenously in dogs with steroid-nonresponsive or severe IHA or IMT. In cats, the same dose is administered orally, because gastrointestinal adverse effects (e.g., vomiting, anorexia) appear to be more common after intravenous injections of this agent.
The oral form of cyclophosphamide can be given on a continuous basis either every other day of for 4 consecutive days followed by 3 days off, at a dose of 50 mg/m2. However, one of the common adverse effects of long term cyclophosphamide treatment in dogs is sterile hemorrhagic cystitis, which frequently develops after 8 to 10 weeks of continuous treatment. Female dogs are at an increased risk for this toxicity and should therefore undergo periodic urinalisys and physical examination while receiving the drug. The concurrent administration of prednisone appears to decrese the risk of cystitis in dogs receiving ongoing cyclophosphamide treatment. Cystitis caused by long-term cyclophosphamide treatment is extremely rare in cats.
Two other common adverse effects of cyclophosphamide include anorexia (mainly in cats) and myelosuppression (in both dogs and cats). Because of this agent's potential to cause myelosuppression, a complete blood count should be performed every 2 to 4 weeks, and the dose adjusted accordingly.
We would love to hear your pet's story. Please add a comment.
Cyclophosphamide (Cytoxan, Mead Johnson, Evansville, Ind) is a very effective immunosuppressive agent for inducing remission in dogs and possibly cats with IMDs. This drug is an alkylator anticancer agent, which appears to suppress cell-mediated and humoral immunity, as well as mononuclear-phagocytic function. It is activated and metabolized by the microsomal fraction of the liver and is available as 25 and 50 mg tablets and injectable vials of 100, 200, 500, and 1000 mg.
Cyclophosphamide has been effective in inducing or consolidating remission in dogs with immune-mediated hemolytic anemia (IHA) or immune-mediated thrombocytopenia (IMT). It is also effective in dogs with immune-mediated polyarthritis, dermatitis, or systemic lupus erythematosus (SLE). It is commonly administered in one dose of 200 to 300 mg/m2 intravenously in dogs with steroid-nonresponsive or severe IHA or IMT. In cats, the same dose is administered orally, because gastrointestinal adverse effects (e.g., vomiting, anorexia) appear to be more common after intravenous injections of this agent.
The oral form of cyclophosphamide can be given on a continuous basis either every other day of for 4 consecutive days followed by 3 days off, at a dose of 50 mg/m2. However, one of the common adverse effects of long term cyclophosphamide treatment in dogs is sterile hemorrhagic cystitis, which frequently develops after 8 to 10 weeks of continuous treatment. Female dogs are at an increased risk for this toxicity and should therefore undergo periodic urinalisys and physical examination while receiving the drug. The concurrent administration of prednisone appears to decrese the risk of cystitis in dogs receiving ongoing cyclophosphamide treatment. Cystitis caused by long-term cyclophosphamide treatment is extremely rare in cats.
Two other common adverse effects of cyclophosphamide include anorexia (mainly in cats) and myelosuppression (in both dogs and cats). Because of this agent's potential to cause myelosuppression, a complete blood count should be performed every 2 to 4 weeks, and the dose adjusted accordingly.
We would love to hear your pet's story. Please add a comment.
MORE VETERINARY ARTICLES
-
The Boston Terrier is a cross between the Bulldog and the English Terrier, but it is distinctive in its own right. Its confirmation, which i...
-
History 1. Family history. 2. Exercise intolerance, syncopal episoded. 3. Pallor, jaundice. 4. Localized or generalized bleeding. 5. Feline ...
-
Small Dogs You shouldn't base your decision of which small dog breed to pick based solely on "looks," or you could end up with...
-
Enlargement of the liver | Hepatomegaly in dogs and cats Enlargement of the liver in dogs and cats may be the result of cardiac incompetenc...
-
The Rottweiler is one of the largest of the more highly respected guard dogs, the others being the Akita , the Doberman Pinscher , and the G...
-
1. Acetaminophen. 2. Antiarrythmics. 3. Anticonvulsants. 4. Antiinflammatories (nonsteroidal). 5. Barbiturates. 6. Benzocaine. 7. Chemothera...
-
The Afghan Hound is one of the most distinguished-looking breeds, which is no doubt the main reason people are attracted to it. The Afghan ...
-
The Alaskan Malamute is larger than either the Siberian Husky or the Samoyed, two other similar breed of sled dogs. As the largest breed of ...
-
If you must find a dog that is not active, excitable or aggressive, the Basset Hound could be ideal for you. Bassets have the reputation of ...
-
Dog Breeds - Groups The breeds of dogs are officially classified into 10 distinct groups, themselves divided into sections, created accord...